Janus Henderson Investors US’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | $18.5M | Sell |
4,392,988
-265,857
| -6% | -$1.12M | 0.02% | 617 |
|
|
2016
Q4 | $19.2M | Sell |
4,658,845
-993,649
| -18% | -$4.1M | 0.02% | 622 |
|
|
2016
Q3 | $45.8M | Sell |
5,652,494
-59,865
| -1% | -$485K | 0.04% | 435 |
|
|
2016
Q2 | $44.6M | Sell |
5,712,359
-1,066,645
| -16% | -$8.32M | 0.04% | 445 |
|
|
2016
Q1 | $52.3M | Sell |
6,779,004
-238,461
| -3% | -$1.84M | 0.05% | 420 |
|
|
2015
Q4 | $75.7M | Sell |
7,017,465
-317,083
| -4% | -$3.42M | 0.06% | 329 |
|
|
2015
Q3 | $50.7M | Buy |
7,334,548
+902,220
| +14% | +$6.23M | 0.05% | 413 |
|
|
2015
Q2 | $57M | Buy |
6,432,328
+1,803,126
| +39% | +$16M | 0.05% | 422 |
|
|
2015
Q1 | $45.6M | Buy |
4,629,202
+1,525,833
| +49% | +$15M | 0.04% | 468 |
|
|
2014
Q4 | $38M | Sell |
3,103,369
-508,610
| -14% | -$6.23M | 0.03% | 498 |
|
|
2014
Q3 | $36M | Buy |
+3,611,979
| New | +$36M | 0.03% | 486 |
|
|
2013
Q4 | – | Sell |
-2,410,741
| Closed | -$7.28M | – | 1116 |
|
|
2013
Q3 | $7.28M | Buy |
2,410,741
+11,878
| +0.5% | +$35.9K | 0.01% | 693 |
|
|
2013
Q2 | $19.6M | Buy |
+2,398,863
| New | +$19.6M | 0.02% | 503 |
|